<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Head and Neck Tumors</journal-id><journal-title-group><journal-title xml:lang="en">Head and Neck Tumors</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли головы и шеи</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-1468</issn><issn publication-format="electronic">2411-4634</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">22</article-id><article-id pub-id-type="doi">10.17650/2222-1468-2013-0-4-20-22</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">THE FIRST EXPERIENCE WITH TISSUCOL AT MOSCOW CITY CANCER HOSPITAL SIXTY-TWO</article-title><trans-title-group xml:lang="ru"><trans-title>ПЕРВЫЙ ОПЫТ ИСПОЛЬЗОВАНИЯ ПРЕПАРАТА ТИССУКОЛ В МОСКОВСКОЙ ГОРОДСКОЙ ОНКОЛОГИЧЕСКОЙ БОЛЬНИЦЕ № 62</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novozhilova</surname><given-names>E. N.</given-names></name><name xml:lang="ru"><surname>Новожилова</surname><given-names>Е. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>E-Novozhilova@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedotov</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Федотов</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novozhilov</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Новожилов</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Paskova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Паскова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Moscow City Cancer Hospital Sixty-Two</institution></aff><aff><institution xml:lang="ru">Московская городская онкологическая больница № 62, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2013</year></pub-date><volume>3</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>20</fpage><lpage>22</lpage><history><date date-type="received" iso-8601-date="2015-04-15"><day>15</day><month>04</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-04-15"><day>15</day><month>04</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Novozhilova E.N., Fedotov A.P., Novozhilov M.V., Paskova M.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Новожилова Е.Н., Федотов А.П., Новожилов М.В., Паскова М.В.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Novozhilova E.N., Fedotov A.P., Novozhilov M.V., Paskova M.V.</copyright-holder><copyright-holder xml:lang="ru">Новожилова Е.Н., Федотов А.П., Новожилов М.В., Паскова М.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ogsh.abvpress.ru/jour/article/view/22">https://ogsh.abvpress.ru/jour/article/view/22</self-uri><abstract xml:lang="en"><p>The paper describes the first experience with the fibrin sealant Tissucol at Moscow City Cancer Hospital Sixty-Two. The authors used this agent in different clinical situations. However, Tissucol showed the highest efficacy in arresting long-term severe lymphorrhea. The described clinical case clearly demonstrates the abilities of this agent and allows it to be recommended for use in other areas of oncology.</p></abstract><trans-abstract xml:lang="ru"><p>В статье представлен первый опыт использования фибринового клея Тиссукол в Московской городской онкологической больнице № 62. Авторы применили данный препарат в различных клинических ситуациях, однако наибольшую эффективность Тиссукол показал при купировании обильной длительной лимфореи. Приведенное клиническое наблюдение ярко демонстрирует возможности данного препарата и позволяет рекомендовать его к использованию в других областях онкологии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>fibrin sealant Tissucol</kwd><kwd>tumor</kwd><kwd>lymphorrhea arrest</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фибриновый клей Тиссукол</kwd><kwd>опухоль</kwd><kwd>купирование лимфореи</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Инструкция по применению Тиссукола.</mixed-citation><mixed-citation xml:lang="ru">Инструкция по применению Тиссукола.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Red H., Cooper M. et al. The influence of lonic additives on fibrin structure and on the morfology and grouth of human fibroblasts / comparison of two fibrin glues. Med Welt 1995;85(22):769–77.</mixed-citation><mixed-citation xml:lang="ru">Red H., Cooper M. et al. The influence of lonic additives on fibrin structure and on the morfology and grouth of human fibroblasts / comparison of two fibrin glues. Med Welt 1995;85(22):769–77.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Gouillat C., Tete B., Frering V. et al. Evaluation of the effectiveness of two fibrin glue for patients undergoing resternotomy or reoperation after cardiac operations. Multicentral Study. J Thorac Cardiovasc Surg 1999;87;234–53.</mixed-citation><mixed-citation xml:lang="ru">Gouillat C., Tete B., Frering V. et al. Evaluation of the effectiveness of two fibrin glue for patients undergoing resternotomy or reoperation after cardiac operations. Multicentral Study. J Thorac Cardiovasc Surg 1999;87;234–53.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Data of file. Baxter Health Corporation 2011, p. 37.</mixed-citation><mixed-citation xml:lang="ru">Data of file. Baxter Health Corporation 2011, p. 37.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
